A potential mechanism of the onset of immune-related pneumonitis triggered by anti-PD-1 treatment in a patient with advanced adenocarcinoma lung cancer: case report

BACKGROUND: In recent years, the application of immunotherapy combined with chemotherapy in the first-line lung cancer has showed significant benefit in improving long-term survival. Immunotherapy also has risks of immune-related pneumonitis (IRP) after long-term treatment. Despite the treatment str...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yu, Chen, Cuncun, Zhao, Liming, Zhu, Xuyou, Zhu, Xiaoping, Li, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438889/
https://www.ncbi.nlm.nih.gov/pubmed/34521373
http://dx.doi.org/10.1186/s12890-021-01649-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438889/
https://www.ncbi.nlm.nih.gov/pubmed/34521373
http://dx.doi.org/10.1186/s12890-021-01649-6

Ejemplares similares